LS

Lalita Sinha

Active Director Director DIN 09061347
DIN 09061347 First appointment Feb 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2021
Shareholding value Locked Premium profile

About Lalita Sinha

Lalita Sinha has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Hospitocare Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09061347
Primary Designation Director
First Appointment 10 Feb 2021
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Director 10 Feb 2021 2020 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hospitocare Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Lalita Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalita Sinha

Lalita Sinha has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Hospitocare Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Lalita Sinha is associated with 1 company as Director.

Lalita Sinha has expertise in General Business.

Lalita Sinha has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available